Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma

SIMPLE SUMMARY: Phytocannabinoids Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) have been demonstrated to exhibit anti-cancer activity in preclinical models of brain cancer leading to new clinical trials for adults with glioblastoma. We describe here the first report that has investigated a ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Andradas, Clara, Byrne, Jacob, Kuchibhotla, Mani, Ancliffe, Mathew, Jones, Anya C., Carline, Brooke, Hii, Hilary, Truong, Alexandra, Storer, Lisa C. D., Ritzmann, Timothy A., Grundy, Richard G., Gottardo, Nicholas G., Endersby, Raelene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829707/
https://www.ncbi.nlm.nih.gov/pubmed/33477420
http://dx.doi.org/10.3390/cancers13020330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829707/
https://www.ncbi.nlm.nih.gov/pubmed/33477420
http://dx.doi.org/10.3390/cancers13020330

Ejemplares similares